Disc Medicine IRON Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -35.9%-8.1pp | -27.7%+1.6pp | -29.3%— | —— | |
| Return on assets | -32.6%-7.3pp | -25.3%+1.6pp | -26.9%+5.1pp | -32%— | |
| Return on invested capital | -49.1%— | —— | —— | —— | |
| Liquidity | |||||
| Current ratio | 21.9×+0.8× | 21.2×+4.1× | 17.1×+8.3× | 8.8×+2.1× | |
| Quick ratio | 21.9×+0.8× | 21.2×+4.1× | 17.1×+8.3× | 8.8×+2.1× | |
| Cash ratio | 2.5×-5.8× | 8.3×-8.6× | 16.8×+8.2× | 8.6×+2.1× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0.1×+0.1× | 0×0.0× | 0×— | |
| Debt-to-assets | 0×0.0× | 0.1×+0.1× | 0×0.0× | 0×0.0× | |
| Interest coverage | -65.4×+161× | -226.8×— | —— | —— | |
| Per Share | |||||
| Book value per share | $20.96+30.4% | $16.07+3.9% | $15.47-90.9% | $169.89+332% | |
| Valuation | |||||
| Market capitalization | $3B+58.9% | $1.89B+38.6% | $1.36B+5,053% | $26.41M-84.2% | |
| Enterprise value | $2.94B+70.4% | $1.72B+72.0% | $1B+701% | -$166.86M-311% | |
| Price / book | 4.1×-0.2× | 4.3×+0.3× | 3.9×+3.8× | 0.1×— | |
| Free cash flow yield | -6%-1.0pp | -5%+0.4pp | -5.4%+155pp | -160.5%— | |
| Earnings yield | -7.1%-1.3pp | -5.8%-0.2pp | -5.6%+172pp | -177.3%— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Disc Medicine's ratios come from?
- Every ratio is computed from Disc Medicine's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.